Skip to main content

Latest SEC Filings — Page 35

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Officer Files Intent to Sell $148K in Shares, Adding to Recent $266K Sales Amidst Financial Distress
ProForm 144CVKD · Form 144 · 4d ago
RA Capital Sells $372K in Werewolf Therapeutics Shares, Reducing Stake Amid Strategic Review
Form SCHEDULE 13D/AHOWL · Form SCHEDULE 13D/A · 4d ago
NextNav to Redeem $186.5M Convertible Notes, Citing Strong Stock Performance
ProForm 8-KNN · Form 8-K · 4d ago
Alpha Modus Discloses Massive Dilution from ATM Sales, Ineffective Controls, and Ongoing Going Concern
ProForm 424B3AMOD · Form 424B3 · 4d ago
S&P Reaffirms AXIA Energia's Credit Ratings, Upgrades Governance Outlook to Neutral
Form 6-KAXIA · Form 6-K · 4d ago
Vivos Therapeutics Forms Strategic Partnership for Sleep Apnea Services in Florida
ProForm 8-KVVOS · Form 8-K · 4d ago
RA Capital Increases Stake with $11.1M Stock Purchases, Now Owns 36.6% of Artiva Biotherapeutics
ProForm SCHEDULE 13D/AARTV · Form SCHEDULE 13D/A · 4d ago
Enterprise Financial Services Finalizes $175M Subordinated Notes Offering
Form 424B5EFSC · Form 424B5 · 4d ago
Biotricity Confirms Aggressive 1-for-100 Reverse Stock Split
ProForm DEF 14CBTCY · Form DEF 14C · 4d ago
Kaival Brands Reports Going Concern Doubt, Revenue Halved, Negative Equity, and Significant Insider Dilution
ProForm 10-QKAVL · Form 10-Q · 4d ago
Fox Corporation to Acquire Roku for $25 Billion in Cash and Stock
ProForm 425ROKU · Form 425 · 4d ago
Juniper Fund Sells $15.6M in LINC Shares, Reducing Stake to 6.8%
ProForm SCHEDULE 13D/ALINC · Form SCHEDULE 13D/A · 4d ago
Moody's Local Upgrades Agibank's Credit Rating to 'AA.br' Post-IPO
ProForm 6-KAGBK · Form 6-K · 4d ago
Atmos Energy Finalizes $700M Senior Notes Offering Due 2032
Form FWPATO · Form FWP · 4d ago
SABESP Appoints New Customer Experience Director, Realigns Executive Board for Strategic Focus
Form 6-KSBS · Form 6-K · 4d ago
Hercules Capital Schedules Investor Calls for Potential Senior Unsecured Notes Offering
Form 497ADHTGC · Form 497AD · 4d ago
CEO Phillip Chan Buys $105K in Open Market Amidst Delisting Threat and Going Concern Warning
ProForm 4CTSO · Form 4 · 4d ago
CEO Sells $5.37M in Shares Ahead of Acquisition
Form 4GBTG · Form 4 · 4d ago
Stockholders Approve Extension of Incentive Plan and Tax Benefits Preservation Plan
Form 8-KSD · Form 8-K · 4d ago
Director (OrbiMed) Purchases $5.0M in Pre-Funded Warrants
ProForm 4STTK · Form 4 · 4d ago
OrbiMed Advisors Buys $5.0M in Pre-Funded Warrants from Public Offering
ProForm 4STTK · Form 4 · 4d ago
OrbiMed Increases Stake to 9.99% via $5M Pre-Funded Warrant Purchase in Recent Offering
Form SCHEDULE 13D/ASTTK · Form SCHEDULE 13D/A · 4d ago
Shareholders Approve Massive Increase in Authorized Common Stock, Enabling Future Dilution
ProForm 8-KUAMY · Form 8-K · 4d ago
BOXABL Partners for UK & Ireland Expansion Ahead of Public Listing
Form 425FGMC · Form 425 · 4d ago
Activist Investor Engine Capital Group Reduces Stake by $5.9 Million
ProForm SCHEDULE 13D/ACVEO · Form SCHEDULE 13D/A · 4d ago
Officer & Director Scott Bibaud Files Intent to Sell $468K in Stock
Form 144ATOM · Form 144 · 4d ago
Terra Innovatum Reports Material Weaknesses, Continued Cash Burn, and PFIC Status in 2025 Annual Report
ProForm 10-KNKLR · Form 10-K · 4d ago
Major Affiliate Files Intent to Sell $273M in CAVA Stock
Form 144CAVA · Form 144 · 4d ago
Silver Lake Sells $23.7M in Dell Shares
Form 4DELL · Form 4 · 4d ago
Officer Dennis Mulroy Files to Sell Additional $1.15M in Stock, Continuing Recent Trend
ProForm 144ANAB · Form 144 · 4d ago